Efficacy of Omega-3 in the treatment of Schizophrenia
Phase 1
- Conditions
- Schizophrenia.The Schizophrenic Disorders Are Characterized in general by fundamental and characteristic distortions of thinking and perception, and affects that are inappropriate or blunted.
- Registration Number
- IRCT201202117373N2
- Lead Sponsor
- Arak University Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
age range 15-55years ,diagnosis of schizophrenia according to DSM4-TR criteria and clinical interview by psychiatrist ,informed written consent letter ,a score of at least 60 in PANSS( Positive and Negative Syndrome Scale).
Exclusion criteria :Pregnancy ,lactation, substance abuse ,sever physical disease,contraindication of Omega-3
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method PANSS. Timepoint: Before Intervention,4th Week,8th Week. Method of measurement: Physical Exam And Clinical Intrview.
- Secondary Outcome Measures
Name Time Method Extra Pyramidal Side Effects. Timepoint: Before Intervention And Once Every 4 Weeks. Method of measurement: Physical Examination And Clinical Interview.